- Home
- UAMY vs THTX Comparison
UAMY vs THTX Comparison
Compare UAMY & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAMY
- THTX
- Stock Information
- Founded
- UAMY 1968
- THTX 1993
- Country
- UAMY United States
- THTX Canada
- Employees
- UAMY N/A
- THTX N/A
- Industry
- UAMY Metal Fabrications
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- UAMY Industrials
- THTX Health Care
- Exchange
- UAMY Nasdaq
- THTX Nasdaq
- Market Cap
- UAMY 67.5M
- THTX 55.3M
- IPO Year
- UAMY N/A
- THTX N/A
- Fundamental
- Price
- UAMY $0.69
- THTX $1.28
- Analyst Decision
- UAMY
- THTX Hold
- Analyst Count
- UAMY 0
- THTX 1
- Target Price
- UAMY N/A
- THTX N/A
- AVG Volume (30 Days)
- UAMY 853.0K
- THTX 47.4K
- Earning Date
- UAMY 11-11-2024
- THTX 10-10-2024
- Dividend Yield
- UAMY N/A
- THTX N/A
- EPS Growth
- UAMY N/A
- THTX N/A
- EPS
- UAMY N/A
- THTX N/A
- Revenue
- UAMY $9,862,364.00
- THTX $84,316,000.00
- Revenue This Year
- UAMY N/A
- THTX $5.87
- Revenue Next Year
- UAMY N/A
- THTX $15.10
- P/E Ratio
- UAMY N/A
- THTX N/A
- Revenue Growth
- UAMY 18.08
- THTX 5.75
- 52 Week Low
- UAMY $0.17
- THTX $0.88
- 52 Week High
- UAMY $0.82
- THTX $2.58
- Technical
- Relative Strength Index (RSI)
- UAMY 48.42
- THTX 53.81
- Support Level
- UAMY $0.67
- THTX $1.20
- Resistance Level
- UAMY $0.74
- THTX $1.32
- Average True Range (ATR)
- UAMY 0.06
- THTX 0.08
- MACD
- UAMY -0.01
- THTX 0.01
- Stochastic Oscillator
- UAMY 16.52
- THTX 60.00
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.